IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer
Amy R. Leslie(University of California, Davis), Allen C. Gao(UC Davis Comprehensive Cancer Center)
Cited by 11
Related Papers
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment
|Molecular Cancer Therapeutics|2022|21